Results 171 to 180 of about 16,485 (262)

Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

American journal of nephrology, 1984
Clinical bleeding in uremia is a frequent problem and seems to correlate with a prolonged bleeding time. The vasopressin analog deamino-8-D-arginine vasopressin has been shown to shorten the bleeding time and to decrease clinical bleeding when administered intravenously to uremic patients.
M. Shapiro, S. Kelleher
semanticscholar   +3 more sources

Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.

Acta Endocrinologica, 1985
Abstract. A sensitive and specific radioimmunoassay for 1-deamino-8-d-arginine vasopressin (DDAVP) was developed. Plasma concentrations of DDAVP after intragastric administration were determined in non-fasted rats and a dose-related increase in plasma levels was obtained.
S. Lundin, P. Melin, H. Vilhardt
semanticscholar   +3 more sources

Osmotic myelinolysis syndrome after treatment of severe deamino arginine vasopressin‐associated hyponatraemia: Pitfalls in emergency medicine

Emergency Medicine Australasia, 2007
AbstractHyponatraemia is among the more common electrolyte abnormalities encountered in the ED. Both the primary disturbance and its correction can result in life‐threatening neurological sequelae. Osmotic myelinolysis syndrome is one such complication and is associated with the rapid correction of hyponatraemia.
M. Gutenstein
semanticscholar   +3 more sources

Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells.

Future Medicinal Chemistry, 2011
Desmopressin (dDAVP), a synthetic nonapeptide derivative of arginine vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agonist for the vasopressin V2 membrane receptor (V2R). It is known that dDAVP can inhibit progression of residual metastatic cells in preclinical models.
N. Iannucci, Giselle V. Ripoll, Juan Garona, O. Cascone, G. Ciccia, D. Gomez, D. Alonso   +6 more
semanticscholar   +3 more sources

Desmopressin Acetate (1-Deamino-8-D-arginine vasopressin, DDAVP) Response Test

, 1989
Exogenously administered desmopressin acetate (1-deamino-S-D-arginine vasopressin, DDAVP) fails to lessen the diuresis in either congenital or acquired nephrogenic diabetes insipidus. These disorders are characterised by renal tubular end-organ resistance to vasopressin, thus differentiating them from hypothalamic/pituitary diabetes insipidus, in which
P. T. Lascelles, D. Donaldson
openaire   +2 more sources

Factor VIII-related activities after 1-deamino-8-D-arginine vasopressin in multicentric reticulohistiocytosis

La Ricerca in Clinica e in Laboratorio, 1984
A woman with multicentric reticulohistiocytosis, having symptoms including bleeding and a borderline level of factor VIII, was given an i.v. infusion of DDAVP as a pharmacological test to evaluate the release of factor VIII-related properties from storage sites.
U, Taddeo, F, Trotta, G, Menegale, G, Ballerini   +3 more
openaire   +3 more sources

SHORTENING OF BLEEDING TIME BY 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VARIOUS BLEEDING DISORDERS

The Lancet, 1984
To evaluate the effect of 1-deamino-8-D-arginine vasopressin (DDAVP) in various bleeding disorders, 10 micrograms/m2 DDAVP was administered to subjects with von Willebrand disease (13), platelet function defects (12), von Willebrand disease and platelet defects together (8), or isolated prolongation of the bleeding time (5).
N. Kobrinsky, J. Gerrard, C. Watson, E. Israels, M. Cheang, A. Bishop, M. Schroeder   +6 more
semanticscholar   +3 more sources

SYNTHESIS AND SOME PHARMACOLOGICAL PROPERTIES OF DEAMINO(4-THREONINE,8-D-ARGININE)VASOPRESSIN AND DEAMINO(8-D-ARGININE)VASOPRESSIN, HIGHLY POTENT AND SPECIFIC ANTIDIURETIC PEPTIDES, AND (8-D-ARGININE)VASOPRESSIN AND DEAMINO-ARGININE-V

Chemischer Informationsdienst, 1976
M. Manning, L. Balaspiri, J. Moehring, J. Haldar, W. Sawyer   +4 more
semanticscholar   +2 more sources

Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study

Journal of Pediatric Hematology/Oncology Nursing
Background: Desmopressin (1-deamino-8-D-arginine vasopressin [DDAVP]) has demonstrated efficacy as a treatment option for patients with inherited bleeding disorders.
Michelle Hallam, Amber Pruett, Charmaine F Biega, Haley Miller, Tami Davis, Linda Casto, Amy L Dunn, Vilmarie Rodriguez   +7 more
semanticscholar   +2 more sources

1-Deamino-8-D-Arginine Vasopressin (DDAVP)

, 2013
Anita Gupta, N. Singh-Radcliff
semanticscholar   +2 more sources